iBio, Inc. (IBIO) Submites Compliance Plan to NYSE Amex
Tweet
Share
E-mail
iBio, Inc. (NYSE AMEX: IBIO) today announced that it has submitted its plan (the "Plan") to satisfy the requirements for continued listing on the NYSE Amex LLC (the "Exchange") to the Exchange's Corporate Compliance Department management (the "Staff") for their review, and that the Company is currently awaiting a response from the Staff in connection therewith. As previously announced, the Staff indicated that its review of the Company's Form 10-K for the year ended June 30, 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick board member to resign after CFO appointment at Best Buy
- Trilogy Metals signs $35.6M investment deal with U.S. Dept. of War
- Zentek shares to move from Nasdaq to OTC Markets on Sept. 2
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
